Reckitt share price near a 52-week high: what to watch before London opens
17 February 2026

Reckitt share price near a 52-week high: what to watch before London opens

London, Feb 17, 2026, 07:48 GMT — Premarket

Reckitt Benckiser slipped 0.74% to close at 6,420 pence on Monday, losing some steam after reaching a 52-week high of 6,478 earlier. Shares moved in a narrow band, fluctuating between 6,418 and 6,478 pence. Roughly 3.7 million shares traded hands.

Markets got a jolt early Tuesday as new UK numbers landed. The fourth quarter saw unemployment ticking up to 5.2%, and wage growth—stripping out bonuses—slipped to 4.2%. Those figures firmed up trader expectations that the Bank of England could be moving toward a rate cut next month.

This week’s flood of UK data could jolt rates, sterling, and shake up where investors park money in the biggest FTSE 100 defensives. London’s blue-chip index eked out a 0.26% gain Monday, with traders eyeing upcoming inflation, retail sales, and business activity figures.

Reckitt shares slipped from near their annual peak, market cap hovering around £41.4 billion. With management due to speak later this week, there’s little tolerance for missteps.

Reckitt’s lineup stretches from Lysol and Dettol to Durex, Nurofen, and Enfamil, selling hygiene, health, and nutrition products around the world. That broad reach exposes the company to currency fluctuations—and to any shifts in consumer habits as borrowing costs ease.

Looking ahead, the next event on the calendar is Thursday, when the Consumer Analyst Group of New York (CAGNY) conference gets underway in Orlando. Reckitt has confirmed that CEO Kris Licht and CFO Shannon Eisenhardt are set to speak on Feb. 19. Their presentation will be webcast from 15:00 to 15:45 GMT.

CAGNY lands mid-quarter and gives a crucial snapshot for the household and consumer health sectors, and several of the major players are lining up this week. Procter & Gamble is scheduled to present just ahead of Reckitt on Thursday, Kimberly-Clark comes up a bit later that morning, and Unilever is also on the docket this week.

Next up for investors: Reckitt’s full-year results hit on March 5. The company’s set to present to investors at the London Stock Exchange, kicking off at 08:30 GMT.

The company’s capital return plan falls somewhere in the middle. Its filings outline a 235 pence-per-share special dividend slated for Feb. 20, with a 24-for-25 share consolidation that went into effect earlier this month—a technical tweak that tends to muddy near-term price comparisons.

Interest rates are still the main driver for the broader market. According to a Reuters poll, a majority of economists see the Bank of England trimming rates by 25 basis points—so, a quarter-point cut—on March 19. Sanjay Raja at Deutsche Bank isn’t budging, saying, “We stick to our call for the next Bank Rate cut to come in March.” Reuters

Sterling dipped roughly 0.29%, touching $1.359 after the jobs numbers landed. For Reckitt, that weaker pound helps overseas revenue look bigger once it’s converted back, but it’s a double-edged sword—some input costs can climb, too.

Still, “defensive” trades aren’t immune to company-level shocks. Reckitt’s been exploring what to do with its Mead Johnson baby formula unit, a business that’s tangled up in litigation. One unfavorable court move, and the risk premium could snap higher in a hurry. Reuters

Coming up in quick succession: Licht and Eisenhardt speaking at CAGNY on Feb. 19, special dividend payout set for Feb. 20, and full-year numbers land March 5.

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Constellation Energy

NASDAQ: CEG 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY

Walt Disney

NYSE: DIS 92 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 90 / 100
#5 BUY ON PULLBACK

Cheniere Energy

NYSE: LNG 88 / 100
View full portfolio
Editorial model selection. Not personalised advice.
GSK share price in focus: £450 million buyback tranche starts as London trading nears
Previous Story

GSK share price in focus: £450 million buyback tranche starts as London trading nears

BAE Systems share price dips as fresh buyback detail lands ahead of results
Next Story

BAE Systems share price dips as fresh buyback detail lands ahead of results